Valuation: Shivalik Rasayan Limited

Market Cap 349.26Cr 3.65Cr 3.15Cr 2.96Cr 2.69Cr 5.07Cr 5.14Cr 35Cr 14Cr 174.98Cr 14Cr 13Cr 582.07Cr P/E 2024
69.1x
P/E 2025 59.1x
Enterprise Value 426.02Cr 4.46Cr 3.85Cr 3.61Cr 3.29Cr 6.18Cr 6.27Cr 42Cr 17Cr 213.44Cr 17Cr 16Cr 709.98Cr EV / Sales 2024
3.49x
EV / Sales 2025 3.4x
Free-Float
41.75%
Yield 2024
0.09%
Yield 2025 0.08%
14/08 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
23/07 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
27/05 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
27/05 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
27/05 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26 CI
27/05 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
13/02 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
14/11 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
29/25/29 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
12/25/12 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/25/30 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
30/25/30 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
24/25/24 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
1 day-4.99%
1 week-0.30%
Current month+2.49%
1 month+16.52%
3 months-2.09%
6 months-7.03%
Current year-28.86%
1 week 250
Extreme 250
269
1 month 215.05
Extreme 215.05
271.4
Current year 206
Extreme 206
371.3
1 year 206
Extreme 206
524
3 years 206
Extreme 206
873.6
5 years 206
Extreme 206
1,196.8
10 years 62.04
Extreme 62.04
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 17/11/2018
Director of Finance/CFO - 01/11/2001
Chief Tech/Sci/R&D Officer - 11/01/2024
Director TitleAgeSince
Chairman 62 23/02/2002
Director/Board Member 67 18/07/2003
Director/Board Member - 13/11/2018
Date Insider Type Main position Quantity % Market Cap.
01/07/24 Don 21,500 0.1382%
26/06/24 Sell 1,08,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
-4.99%-0.30%-51.34%-67.70% 4.39Cr
-0.87%-0.60%+5.15%+50.72% 5.12TCr
+0.11%-.--%-.--%-.--% 1.3TCr
-0.13%+0.20%+20.98%+170.68% 1.06TCr
+2.25%-1.86%+13.53%+71.25% 780.86Cr
-1.62%+2.25%-12.78%-10.93% 716.32Cr
-1.79%-5.50%-17.69%+74.26% 546.57Cr
+1.14%+2.09%+38.24%+49.38% 517.24Cr
+0.57%-0.68%-16.95%-3.70% 498.61Cr
-0.64%-10.09%-32.65%-35.03% 396.63Cr
Average -0.56%-0.16%-5.35%+29.89% 1.09TCr
Weighted average by Cap. -0.24%-0.01%+3.51%+49.20%

Financials

2024 2025
Net sales 271.54Cr 2.84Cr 2.45Cr 2.3Cr 2.1Cr 3.94Cr 3.99Cr 27Cr 11Cr 136.04Cr 11Cr 10Cr 452.54Cr 309.55Cr 3.24Cr 2.79Cr 2.62Cr 2.39Cr 4.49Cr 4.55Cr 31Cr 12Cr 155.08Cr 12Cr 12Cr 515.88Cr
Net income 13Cr 13.3L 11.48L 10.77L 10L 18.45L 18.7L 1.26Cr 49.49L 6.37Cr 49.94L 48.86L 21Cr 17Cr 17.46L 15.08L 14.14L 12.88L 24.22L 24.56L 1.66Cr 64.97L 8.36Cr 65.56L 64.14L 28Cr
Net Debt 48Cr 50.44L 43.55L 40.85L 37.21L 69.97L 70.94L 4.79Cr 1.88Cr 24Cr 1.89Cr 1.85Cr 80Cr 77Cr 80.28L 69.3L 65.02L 59.22L 1.11Cr 1.13Cr 7.62Cr 2.99Cr 38Cr 3.01Cr 2.95Cr 127.92Cr
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
275
Date Price Change Volume
17/26/17 253.15 -4.99% 3,527
14/26/14 ₹266.45 +1.72% 2,439
13/26/13 ₹261.95 -2.51% 4,163
12/26/12 ₹268.70 +3.75% 2,898
11/26/11 ₹259.00 +0.15% 3,535
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock